The human pupil as a model for clinical pharmacological investigations.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001337:Autonomic Agents / Q000494:pharmacology*; D001341:Autonomic Nervous System / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D004402:Dysautonomia, Familial / Q000175:diagnosis; D005123:Eye / Q000294:innervation; D006732:Horner Syndrome / Q000175:diagnosis; D006801:Humans; D006973:Hypertension / Q000175:diagnosis; D006980:Hyperthyroidism / Q000175:diagnosis; D007223:Infant; D007231:Infant, Newborn; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D011680:Pupil / Q000187:drug effects*; D012025:Reflex, Pupillary / Q000187:drug effects; D012107:Research Design; D013565:Sympatholytics / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D001337:Autonomic Agents; D008996:Monoamine Oxidase Inhibitors; D010276:Parasympatholytics; D013565:Sympatholytics